CTLA4 and neoplasm: For example, Bifidobacterium-derived inosine improves anti-CTLA-4 treatment efficacy in colorectal cancer [28, 32], whereas in hepatocellular carcinoma, microbial metabolites such as fatty acids promote tumor progression via direct interactions with tumor cells [33].